Literature DB >> 4019641

High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids.

J Godbillon, S Gauron, J P Metayer.   

Abstract

Sensitive and selective high-performance liquid chromatographic assays for diclofenac and its monohydroxylated metabolites in biological fluids are described. Using ultraviolet detection at 282 nm, diclofenac is assayed in plasma at concentrations down to 10 ng/ml; total (free + conjugated) diclofenac and its monohydroxylated metabolites (the sum of 3'- + 4'-hydroxydiclofenac and 5-hydroxydiclofenac) are assayed in urine after chemical hydrolysis at concentrations down to 200 ng/ml. The applicability of the described assays is shown.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4019641     DOI: 10.1016/0378-4347(85)80079-7

Source DB:  PubMed          Journal:  J Chromatogr


  12 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

2.  The relative bioavailability of diclofenac with respect to time of administration.

Authors:  M Mustofa; S Suryawati; I Dwiprahasto; B Santoso
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

3.  A new approach to the compartmental analysis in pharmacokinetics: fractional time evolution of diclofenac.

Authors:  Jovan K Popović; Milica T Atanacković; Ana S Pilipović; Milan R Rapaić; Stevan Pilipović; Teodor M Atanacković
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-01-14       Impact factor: 2.745

4.  Evaluation of statistical power function for various diclofenac bioequivalence trials with different subject numbers.

Authors:  Jovan Popović; Momir Mikov; Ana Sabo; Vida Jakovljević
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Apr-Jun       Impact factor: 2.441

5.  Regional drug delivery II: relationship between drug targeting index and pharmacokinetic parameters for three non-steroidal anti-inflammatory drugs using the rat air pouch model of inflammation.

Authors:  A J Stevens; S W Martin; B S Brennan; A McLachlan; L A Gifford; M Rowland; J B Houston
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

6.  Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved.

Authors:  W S Beck; H T Schneider; K Dietzel; B Nuernberg; K Brune
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

7.  Are altered pharmacokinetics of non-steroidal anti-inflammatory drugs (NSAIDs) a risk factor for gastrointestinal bleeding?

Authors:  H A Wynne; A Long; E Nicholson; A Ward; D Keir
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

8.  Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans.

Authors:  D J Carlile; N Hakooz; M K Bayliss; J B Houston
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

9.  Analysis of diclofenac and four of its metabolites in human urine by HPLC.

Authors:  R J Sawchuk; J A Maloney; L L Cartier; R J Rackley; K K Chan; H S Lau
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

10.  Biliary elimination of non-steroidal anti-inflammatory drugs in patients.

Authors:  H T Schneider; B Nuernberg; K Dietzel; K Brune
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.